Cargando…

Evaluation of CSF albumin quotient in neuronal surface antibody-associated autoimmune encephalitis

BACKGROUND AND OBJECTIVES: Disruption of brain barriers is considered to be involved in the pathogenesis of neuronal surface antibody-associated autoimmune encephalitis (NSAE), but few studies have focused on their relationship. We aimed to explore the association between the integrity of brain barr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Qi-Lun, Cai, Meng-Ting, Zheng, Yang, Fang, Gao-Li, Du, Bing-Qing, Shen, Chun-Hong, Wang, Jia-Jia, Weng, Qin-Jie, Zhang, Yin-Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685895/
https://www.ncbi.nlm.nih.gov/pubmed/36419157
http://dx.doi.org/10.1186/s12987-022-00392-2
_version_ 1784835621089443840
author Lai, Qi-Lun
Cai, Meng-Ting
Zheng, Yang
Fang, Gao-Li
Du, Bing-Qing
Shen, Chun-Hong
Wang, Jia-Jia
Weng, Qin-Jie
Zhang, Yin-Xi
author_facet Lai, Qi-Lun
Cai, Meng-Ting
Zheng, Yang
Fang, Gao-Li
Du, Bing-Qing
Shen, Chun-Hong
Wang, Jia-Jia
Weng, Qin-Jie
Zhang, Yin-Xi
author_sort Lai, Qi-Lun
collection PubMed
description BACKGROUND AND OBJECTIVES: Disruption of brain barriers is considered to be involved in the pathogenesis of neuronal surface antibody-associated autoimmune encephalitis (NSAE), but few studies have focused on their relationship. We aimed to explore the association between the integrity of brain barriers and clinical and paraclinical characteristics in patients with NSAE. METHODS: This retrospective study consecutively recruited patients with NSAE. The cerebrospinal fluid (CSF) / serum albumin quotient (Qalb) was used to evaluate the function of brain barriers. The data on demographic information, clinical manifestations, magnetic resonance imaging (MRI), CSF findings and prognosis were collected and analyzed. RESULTS: Of the 93 patients included, 33 (35.5%) patients were assigned to the elevated Qalb group and 60 (64.5%) patients to the normal Qalb group. Males and prodromal symptoms were more common in elevated Qalb group (both P < 0.05). The CSF white blood cell, protein, immunoglobulin G and albumin were significantly higher in elevated Qalb group (all P < 0.05). Patients with elevated Qalb were more likely to have brain lesions on MRI (60.6% versus 33.3%, P = 0.011). The modified Rankin Scale (mRS) scores at discharge and at last follow-up were significantly higher in patients with elevated Qalb than those with normal Qalb (both P < 0.05). After univariate and multivariate analyses, Qalb elevation (adjusted odds ratio = 3.96, 95% confidence interval = 1.15–13.59, P = 0.029) was demonstrated as the only independent risk factor for a poor prognosis. DISCUSSION: Males, prodromal symptoms, brain lesions on MRI, CSF pleocytosis, and elevated CSF protein were more common in NSAE patients with increased Qalb. Qalb elevation was an independent prognostic indicator for a poor prognosis in NSAE. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12987-022-00392-2.
format Online
Article
Text
id pubmed-9685895
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96858952022-11-25 Evaluation of CSF albumin quotient in neuronal surface antibody-associated autoimmune encephalitis Lai, Qi-Lun Cai, Meng-Ting Zheng, Yang Fang, Gao-Li Du, Bing-Qing Shen, Chun-Hong Wang, Jia-Jia Weng, Qin-Jie Zhang, Yin-Xi Fluids Barriers CNS Research BACKGROUND AND OBJECTIVES: Disruption of brain barriers is considered to be involved in the pathogenesis of neuronal surface antibody-associated autoimmune encephalitis (NSAE), but few studies have focused on their relationship. We aimed to explore the association between the integrity of brain barriers and clinical and paraclinical characteristics in patients with NSAE. METHODS: This retrospective study consecutively recruited patients with NSAE. The cerebrospinal fluid (CSF) / serum albumin quotient (Qalb) was used to evaluate the function of brain barriers. The data on demographic information, clinical manifestations, magnetic resonance imaging (MRI), CSF findings and prognosis were collected and analyzed. RESULTS: Of the 93 patients included, 33 (35.5%) patients were assigned to the elevated Qalb group and 60 (64.5%) patients to the normal Qalb group. Males and prodromal symptoms were more common in elevated Qalb group (both P < 0.05). The CSF white blood cell, protein, immunoglobulin G and albumin were significantly higher in elevated Qalb group (all P < 0.05). Patients with elevated Qalb were more likely to have brain lesions on MRI (60.6% versus 33.3%, P = 0.011). The modified Rankin Scale (mRS) scores at discharge and at last follow-up were significantly higher in patients with elevated Qalb than those with normal Qalb (both P < 0.05). After univariate and multivariate analyses, Qalb elevation (adjusted odds ratio = 3.96, 95% confidence interval = 1.15–13.59, P = 0.029) was demonstrated as the only independent risk factor for a poor prognosis. DISCUSSION: Males, prodromal symptoms, brain lesions on MRI, CSF pleocytosis, and elevated CSF protein were more common in NSAE patients with increased Qalb. Qalb elevation was an independent prognostic indicator for a poor prognosis in NSAE. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12987-022-00392-2. BioMed Central 2022-11-23 /pmc/articles/PMC9685895/ /pubmed/36419157 http://dx.doi.org/10.1186/s12987-022-00392-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Lai, Qi-Lun
Cai, Meng-Ting
Zheng, Yang
Fang, Gao-Li
Du, Bing-Qing
Shen, Chun-Hong
Wang, Jia-Jia
Weng, Qin-Jie
Zhang, Yin-Xi
Evaluation of CSF albumin quotient in neuronal surface antibody-associated autoimmune encephalitis
title Evaluation of CSF albumin quotient in neuronal surface antibody-associated autoimmune encephalitis
title_full Evaluation of CSF albumin quotient in neuronal surface antibody-associated autoimmune encephalitis
title_fullStr Evaluation of CSF albumin quotient in neuronal surface antibody-associated autoimmune encephalitis
title_full_unstemmed Evaluation of CSF albumin quotient in neuronal surface antibody-associated autoimmune encephalitis
title_short Evaluation of CSF albumin quotient in neuronal surface antibody-associated autoimmune encephalitis
title_sort evaluation of csf albumin quotient in neuronal surface antibody-associated autoimmune encephalitis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685895/
https://www.ncbi.nlm.nih.gov/pubmed/36419157
http://dx.doi.org/10.1186/s12987-022-00392-2
work_keys_str_mv AT laiqilun evaluationofcsfalbuminquotientinneuronalsurfaceantibodyassociatedautoimmuneencephalitis
AT caimengting evaluationofcsfalbuminquotientinneuronalsurfaceantibodyassociatedautoimmuneencephalitis
AT zhengyang evaluationofcsfalbuminquotientinneuronalsurfaceantibodyassociatedautoimmuneencephalitis
AT fanggaoli evaluationofcsfalbuminquotientinneuronalsurfaceantibodyassociatedautoimmuneencephalitis
AT dubingqing evaluationofcsfalbuminquotientinneuronalsurfaceantibodyassociatedautoimmuneencephalitis
AT shenchunhong evaluationofcsfalbuminquotientinneuronalsurfaceantibodyassociatedautoimmuneencephalitis
AT wangjiajia evaluationofcsfalbuminquotientinneuronalsurfaceantibodyassociatedautoimmuneencephalitis
AT wengqinjie evaluationofcsfalbuminquotientinneuronalsurfaceantibodyassociatedautoimmuneencephalitis
AT zhangyinxi evaluationofcsfalbuminquotientinneuronalsurfaceantibodyassociatedautoimmuneencephalitis